Invention Grant
US08975072B2 Human erythroid progenitor cell line comprising HPV E6/E7 operably linked to an inducible promoter and method for producing human enucleated red blood cells
有权
包含可操作地连接到诱导型启动子的HPV E6 / E7的人类红系祖细胞系和用于产生人取出的红细胞的方法
- Patent Title: Human erythroid progenitor cell line comprising HPV E6/E7 operably linked to an inducible promoter and method for producing human enucleated red blood cells
- Patent Title (中): 包含可操作地连接到诱导型启动子的HPV E6 / E7的人类红系祖细胞系和用于产生人取出的红细胞的方法
-
Application No.: US13745178Application Date: 2013-01-18
-
Publication No.: US08975072B2Publication Date: 2015-03-10
- Inventor: Yukio Nakamura , Ryo Kurita
- Applicant: Riken
- Applicant Address: JP Saitama
- Assignee: Riken
- Current Assignee: Riken
- Current Assignee Address: JP Saitama
- Agency: Sughrue Mion, PLLC
- Priority: JP2012-161878 20120720
- Main IPC: C12N5/02
- IPC: C12N5/02 ; C12N5/07 ; C12N15/85 ; C12N15/86 ; C12N5/078

Abstract:
Provided are: a method for producing an immortalized human erythroid progenitor cell line, enabling efficient and stable production of enucleated red blood cells; and a method for producing human enucleated red blood cells from a human erythroid progenitor cell line obtained by the aforementioned production method. An expression cassette capable of inducing expression of HPV-E6/E7 genes in the presence of DOX was introduced into the genomic DNA of blood stem cells. Then, the blood stem cells were cultured in the presence of DOX and a blood growth factor. Thereby, immortalized cell lines of human erythroid progenitor cells were established. Further, it was revealed that culturing the cell lines under a condition where the expression of the HPV-E6/E7 genes was not induced enabled differentiation induction into enucleated red blood cells at a high ratio.
Public/Granted literature
- US20140024118A1 HUMAN ERYTHROID PROGENITOR CELL LINE AND METHOD FOR PRODUCING HUMAN ENUCLEATED RED BLOOD CELLS Public/Granted day:2014-01-23
Information query